Dec 11, 2024
Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024
Dec 09, 2024
Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
Nov 14, 2024
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
Positive Data from Phase II Trial in Soft Tissue Sarcoma Presented at CTOS 2024 Annual Meeting
Oct 28, 2024
Immutep Quarterly Activities Report Q1 FY25
